Yu.L. Mizernitskiy

Yu.L. Mizernitskiy

Auto-generated profile, based on publicly available information

Yu.L. Mizernitskiy

Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2022 in PULMONOLOGIYA
Verified
Journal Article
Closed access
PDF file
EKElena Kondatyeva
Elena Kondatyeva
SASergey Avdeev
Sergey Avdeev
YMYu. L. Mizernitskiy
Yu. L. Mizernitskiy
Aleksander V. PolyakovAleksander V. Polyakov
Aleksander V. Polyakov
MCMarina Chernukha
Marina Chernukha
ЮМЮ. Л. Мизерницкий
Ю. Л. Мизерницкий
Primary ciliary dyskinesia (PCD) is a rare hereditary disease from the group of ciliopathies, which is based on a defect in the cilia ultrastructure of the respiratory epithelium and similar structures (sperm flagella, villi of the fallopian tubes, ventricular ependyma, etc.), leading to motor function impairment. The prevalence of the disease varies significantly around the world and is not known reliably in the Russian Federation.The aim of the review was to analyze literature data on modern approaches to the diagnosis and treatment of PCD.Methodology. The data of 90 articles and the opinions of experts providing care to patients with PCD were used.Results. The classic manifestations of PCD depend on age. The leading manifestations of the disease in patients with PCD are recurrent inflammatory diseases of the upper and lower respiratory tract (bronchitis, pneumonia), with the formation of bronchiectasis, damage to the ENT organs (chronic rhinitis, rhinosinusitis, nasal polyposis, repeated otitis media, progressive hearing loss). Currently, there is no single method which could serve as a “gold” standard for diagnosing PCD. The diagnosis of PCD is based on the characteristic clinical picture in combination with the results of special tests (nitric oxide in exhaled air, DNA diagnostics, high-speed video microscopy, transmission electron microscopy). The genetic diagnostics has not been developed sufficiently in the global practice yet and is unavailable in our country. The approach to the treatment of a patient with PCD should be multidisciplinary due to multiple organ lesions. According to the European consensus, the goal of PCD therapy is to restore or maintain normal lung function. There have been no randomized trials of treatment for PCD, and therefore all treatment recommendations are based on very low-level evidence or extrapolated from cystic fibrosis guidelines. Recommendations on mucolytic, antibacterial and anti-inflammatory therapy of PCD are given with consideration for the international and domestic experience.Conclusion. The development of a new version of clinical guidelines containing up-to-date relevant information will improve the diagnosis and treatment of PCD in the Russian Federation.

9 March 2020 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
VKV. K. Kotlukov
V. K. Kotlukov
NAN. V. Antipova
N. V. Antipova
Гигиенические аспекты поддержания эффективного носового дыхания у детей

10 April 2019 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
TKT.V. Kazyukova
T.V. Kazyukova
LIL.I. Ilyenko
L.I. Ilyenko
VKV.K. Kotlukov
V.K. Kotlukov
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.

14 December 2020 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
TMT.G. Malanicheva
T.G. Malanicheva
YMYu.L. Mizernitskiy
Yu.L. Mizernitskiy
EAE.V. Agafonova
E.V. Agafonova
SMS.S. Mozhgina
S.S. Mozhgina
KTKazan Children'S Republican Clinical Hospital With The Ministry Of Healthcare Of The Republic Of Tatarstan
Kazan Children'S Republican Clinical Hospital With The Ministry Of Healthcare Of The Republic Of Tatarstan
Objective of the research: in-depth study of local immunity indices in children with recurrent respiratory diseases (RRD) who fell ill with community-acquired pneumonia (CAP) to optimize immunotherapy. Materials and methods: 83 children aged 3 to 7 years with CAP were under observation. The main group included 50 children with RRD who fell ill with CAP. The comparison group included 33 preschool children with good body's resistance (not belonging to the group of frequently ill children with IR values of 0,2–0,3) who fell ill with CAP. Methods: the indicators of mucosal immunity of induced sputum with an assessment of its cellular composition, the severity of destructive changes in the neutrophil population and phagocytic activity of neutrophilic granulocytes were studied. Intraleukocyte microbicidal system of neutrophil, the level of main classes immunoglobulins and sIgA were assessed. The local cytokine profile was studied by the content of pro-inflammatory and anti-inflammatory cytokines (IL-4, IL-8, IL-10, TNFα, IFNγ). Results: the study revealed a pronounced imbalance between different functional characteristics of neutrophilic granulocytes – along with depression of neutrophil release in children with RRD, there is an increase in the number of neutrophils with signs of nucleus and cytoplasm destruction. Inhibition of cytotoxic activity, manifested by a decrease in oxygen-dependent biocidal activity and inhibition of the intraleukocytic microbicidal system of neutrophils was revealed. It was shown that inhibition of immunoglobulins synthesis and imbalance in the system of local synthesis of pro-inflammatory and anti-inflammatory cytokines are important factors in the disorders of local mucosal profile. Against the background of the revealed disorders of mucosal immunity, there is a longer dynamics of relief of main CAP clinical and radiological symptoms in children with RRD, which provides a scientific justification for the including of immunocorrective therapy in the treatment complex for these patients.

27 April 2023 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
AKA. V. Kamaev
A. V. Kamaev
YMYu. L. Mizernitsky
Yu. L. Mizernitsky
NSN. L. Shaporova
N. L. Shaporova
МММ. Л. Мизерницкий
М. Л. Мизерницкий
Volatility of certain bronchial asthma (BA) phenotype markers is not enough investigated during maturation of pediatric patients. Material and methods. One hundred thirty-one patients with non-severe BA were included; by the age on inclusion date subgroups of “Children” (62 patients aged 6 to 11 years) and “Adolescents” (69 patients aged 12–17 years) were allocated. Every 6 months patients were examined, fulfi d asthma control questionnaires, performed spirometry with salbutamol test, provided hematology results with absolute eosinophil count and height and weight data. Exacerbation and hospitalization numbers, BA severity and controller treatment step were considered. Acquired data were archived; patients’ management was driven by real clinical practice algorithms.Results. Ninety-three patients included (71%) completed at least decade observation. Adolescents and young adults had body mass index higher than 90th percentile by age more often than younger children; some patients had normalized their body mass during observation. BMI and ACT results had moderate reverse correlation (r=–0.64). Eosinophil counts more than 300 cells per microliter conserved longer in older patients: duration median and [Q1; Q3] for “Adolescents” were 11,7 [9,6; 15,3] months and 9.3 [4.8; 11.1] months for “Children” subgroup, difference was significant (р=0.043). Most lung functional parameters were in age normal range. Rare cases of functional obstruction were not stable and did not differ in duration between “Children” 7.3 [6.2; 8.8] months and “Adolescents” 8.4 [6.5; 10.4] months.Conclusion. Phenotype markers of future BA exacerbation risk are quite volatile in pediatric patients and young adults. We recommend repeated evaluation of such markers every 12–18 month of observation to decide on asthma controller change. Simultaneous detection of several markers was quite often but did not lead to more severe asthma course in most patients. Longer duration of elevated BMI or peripheral blood eosinophils were typical for patients with more often BA exacerbations.